Paeds Cases · clinical-pharmacology-and-therapeutics
Endocrine and diabetes medicines OSCE — DKA insulin and fluid prescribing with family counselling
Observed structured encounter testing the DKA insulin and fluid prescribing sequence, the rationale for the insulin infusion rate and no-bolus rule, pump-failure safety counselling, and structured transition of an adolescent insulin regimen to adult care.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 7-year-old presents in diabetic ketoacidosis. The candidate must sequence the fluid and insulin prescribing, justify the infusion rate and the no-bolus rule, and explain the pump-failure and sick-day safety plan to the family.
Candidate brief
You have 10 minutes. [4]
- Sequence the immediate fluid and insulin prescribing for this child's diabetic ketoacidosis, including the insulin infusion rate and the rule on insulin boluses. [4]
- Explain to the examiner why insulin — not fluids or bicarbonate — is the definitive treatment, and why a steep glucose fall is avoided. [4] [9]
- Outline the transition from intravenous insulin back to a subcutaneous regimen, including the insulin classes you would choose. [1]
- Explain the pump-failure and sick-day safety plan to her mother in language she can repeat back. [1]
References4ShowHide
- [1]Cengiz E, Danne T, et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes Horm Res Paediatr, 2024.PMID 39884261
- [4]Wolfsdorf JI, Glaser N, et al ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state Pediatr Diabetes, 2018.PMID 29900641
- [9]Azova S, Rapaport R, et al Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema Pediatr Diabetes, 2021.PMID 33197066
- [2]de Bock M, Agwu JC, et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets Horm Res Paediatr, 2024.PMID 39701064